The prognosis of non-small cell lung cancer varies depending on the specific subtype and the stage of cancer at diagnosis.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

while women have a one in 18 chance. Notably, Black men are 12% more likely than White men to develop lung cancer, whereas Black women are 16% less likely than their White counterparts. 3 1.

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had ... Forty-one had progressive disease at ...